Abstract
Liver cancer is the fifth most common cancer worldwide and unlike certain other cancers, such as colon cancer, a mutational model has not yet been developed. We have performed gene expression profiling of normal and neoplastic livers in C3H/HeJ mice treated with diethylnitrosamine. Using oligonucleotide microarrays, we compared gene expression in liver tumors to three different states of the normal liver: quiescent adult, regenerating adult, and newborn. Although each comparison revealed hundreds of differentially expressed genes, only 22 genes were found to be deregulated in the tumors in all three comparisons. Three of these genes were examined in human hepatocellular carcinomas and were found to be upregulated. As a second method of analysis, we used Representational Difference Analysis (RDA) to clone mRNA fragments differentially expressed in liver tumors versus regenerating livers. We cloned several novel mRNAs that are differentially regulated in murine liver tumors. Here we report the sequence of a novel cDNA whose expression is upregulated in both murine and human hepatocellular carcinomas. Our results suggest that DEN-treated mice provide an excellent model for human hepatocellular carcinomas.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ariel I, Miao HQ, Ji XR, Schneider T, Roll D, de Groot N, Hochberg A, Ayesh S . 1998 Mol. Path. 51: 21–25
Bennett LM, Farnham PJ, Drinkwater NR . 1995 Mol. Carcin. 14: 46–52
Bosch FX, Ribes J, Borras J . 1999 Semin. Liver Dis. 19: 271–285
Buendia MA . 2000 Semin. Cancer Biol. 10: 185–200
Chen S, Guttridge DC, You Z, Zhang Z, Fribley A, Mayo MW, Kitajewski J, Wang C . 2001 J. Cell Biol. 152: 87–96
Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, Eisenman RN, Golub TR . 2000 Proc. Natl. Acad. Sci. USA 97: 3260–3265
Farber E . 1976 The pathology of experimental liver cell cancer Liver Cell Cancer. Cameron HM, Linsell DA and Warwick GP. (eds). Elsevier Scientific Publishing Company: New York pp. 243–277
Hubank M, Schatz DG . 1994 Nucleic Acids Res. 22: 5640–5648
Hubank M, Schatz DG . 1999 Methods Enzymol. 303: 325–349
Kojiro M, Nakashima O . 1999 Semin. Liver Dis. 19: 287–296
Lukas ER, Bartley SM, Graveel CR, Diaz ZM, Dyson N, Harlow E, Yamasaki L, Farnham PJ . 1999 Mol. Carcin. 25: 295–303
Parkin DM, Pisani P, Ferlay J . 1999 Int. J. Cancer 80: 827–841
Schultz J, Copley RR, Doerks T, Ponting CP, Bork P . 2000 Nucleic Acids Res. 28: 231–234
Schultz J, Milpetz F, Bork P, Ponting CP . 1998 Proc. Natl. Acad. Sci. USA 95: 5857–5864
Shijubo N, Uede T, Kon S, Maeda M, Segawa T, Imada A, Hirasawa M, Abe S . 1999 Am. J. Respir. Crit. Care Med. 160: 1269–1273
Singhal H, Bautista DS, Tonkin KS, O'Malley FP, Tuck AB, Chambers AF, Harris JF . 1997 Clin. Cancer Res. 3: 605–611
Slansky JE, Li Y, Kaelin WG, Farnham PJ . 1993 Mol. Cell. Biol. [author’s correction, 13 7201]
Tuck AB, Arsenault DM, O'Malley FP, Hota C, Ling MC, Wilson SM, Chambers AF . 1999 Oncogene 18: 4237–4246
Tuck AB, O'Malley FP, Singhal H, Harris JF, Tonkin KS, Kerkvliet N, Saad Z, Doig GS, Chambers AF . 1998 Int. J. Cancer 79: 502–508
Ue T, Yokozaki H, Kitadai Y, Yamamoto S, Yasui W, Ishikawa T, Tahara E . 1998 Int. J. Cancer 79: 127–132
Welford SM, Gregg J, Chen E, Garrison D, Sorensen PH, Denny CT, Nelson SF . 1998 Nucleic Acids Res. 26: 3059–3065
Yamada Y, Karasaki H, Matsushima K, Lee GH, Ogawa K . 1999 Lab. Invest. 79: 1059–1067
Ye X, Lu L, Gill SS . 1997 Biochem. Biophys. Res. Commun. 239: 660–665
Yoong KF, Afford SC, Jones R, Aujla P, Qin S, Price K, Hubscher SG and Adams DH . 1999 Hepatology 30: 100–111
Acknowledgements
The authors thank J Messamore, E Perguson, S Bartley, Z Diaz, E Lukas and E Armstrong for technical assistance; G Kennedy for the HepG2 cells; J Menetski for collaborative efforts; and the Farnham lab and M Ryan for helpful discussions and critical review of the manuscript. We also thank Dr T Warner and the National Disease Research Interchange for the human tissues. This work was supported in part by research grants from National Cancer Institute/National Institutes of Health CA22484 and National Institute of General Medical Sciences/National Institutes of Health GM08349.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Graveel, C., Jatkoe, T., Madore, S. et al. Expression profiling and identification of novel genes in hepatocellular carcinomas. Oncogene 20, 2704–2712 (2001). https://doi.org/10.1038/sj.onc.1204391
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204391
Keywords
This article is cited by
-
Insulin treatment improves liver histopathology and decreases expression of inflammatory and fibrogenic genes in a hyperglycemic, dyslipidemic hamster model of NAFLD
Journal of Translational Medicine (2021)
-
Analysis of significant protein abundance from multiple reaction-monitoring data
BMC Systems Biology (2018)
-
Alkaline ceramidase 2 is a novel direct target of p53 and induces autophagy and apoptosis through ROS generation
Scientific Reports (2017)
-
Involvement of regucalcin as a suppressor protein in human carcinogenesis: insight into the gene therapy
Journal of Cancer Research and Clinical Oncology (2015)
-
Identification and characterization of CRG-L2, a new marker for liver tumor development
Oncogene (2003)